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Abstract
Background: The last decades have for patients with inflammatory rheumatic diseases seen a shift towards more
physically active rehabilitation programs, often provided as out-patients with less use of inpatient facilities. There is
little research on which effect the multidisciplinary team has on health outcomes for patients with rheumatoid
arthritis, psoriatic arthritis, ankylosing spondylitis, and connective tissue disease. This study examined patient
reported outcomes for patients with inflammatory rheumatic diseases receiving rehabilitation care as inpatients in
departments of rheumatology, and studied how number of consultations with the multidisciplinary team affected
these clinical outcomes.
Methods: Patients with inflammatory rheumatic diseases were included in a multi-center prospective observational
study if rehabilitation was considered a focus during an inpatient stay at four departments of rheumatology. At
admission, discharge, and after 3 and 6 months, 317 patients were assessed with patients reported outcomes (PRO)
including health assessment questionnaire (HAQ), short-form 36 (SF-36), pain, fatigue, patient global assessment of
disease activity, self-efficacy scales, rheumatoid arthritis disease activity index (RADAI), and SF-6D utility. Patients
stated consultations with the multidisciplinary team.
Results: Improvements were short-lived, and at 6 months follow-up period only mental health, pain and utility
remained improved with small effect sizes. Extensive involvement of health professionals was not associated with
improved outcomes.
Conclusions: Patients with inflammatory rheumatic disease receiving inpatient multidisciplinary rehabilitation had
small and mainly short-term improvements in most PROs. High use of the multidisciplinary team did not enhance
or preserve rehabilitation outcomes in inflammatory rheumatic conditions when admitted as inpatients.
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Background
Musculoskeletal diseases are among the most regular
complaints in the general population [1]. Recommmen-
datations highlight a multidisciplinary team care ap-
proach for the best management in musculoskeletal
conditions [2], but there is limited evidence for effects.
Effective management of RA requires a range of non-
pharmacological interventions [3], which are delivered
by members of the multidisciplinary team. Applicable
approaches are for example a combination of physical
exercise and cognitive behavioural therapy [4] or a com-
bination of physical exercise, surgery and diet [5], and
often consist of broad education programmes [6–8]. The
multidisciplinary team may consist of rheumatologists,
rehabilitation specialists, occupational therapists, phys-
ical therapists, social workers, nurses, manual therapists,
podiatrists, dieticians, psychologists, vocational counsel-
lors and orthopaedic surgeons.
Inpatient multidisciplinary care over a short time has
demonstrated effect in active patients with rheumatoid
arthritis (RA) [9] and ankylosing spondylitis [10] as well
as in patients with inflammatory and non-inflammatory
musculoskeletal diseases [11]. A systematic review found
inpatient multidisciplinary care more effective compared
to regular outpatient care [12], while some studies found
equivalent clinical effects between inpatient and day-
care [13, 14] or outpatient [15] team care programmes.
Care in the field of rheumatology has in the last
decades moved towards more physically active re-
habilitation programs provided as out-patients, a de-
velopment which could provide access to a larger
multidisciplinary team. Another development during
recent years has been that patients referred to multi-
disciplinary rehabilitation present with lower levels of
physical disability than previously, but still benefit
from multidisciplinary rehabilitation for their inflam-
matory joint diseases in an era where effective
pharmacological therapies are widely available [16].
Thus, given the effectiveness of inpatient rehabilita-
tion, we hypothesized that rehabilitation also is effect-
ive when provided in rheumatology departments, and
also that the extent to which the multidisciplinary
team is involved would be reflected in rehabilitation
outcomes among patients with specific inflammatory
rheumatic diseases.
The objective of this study was thus to examine 6-
month outcomes of patients with different inflammatory
rheumatic diseases who were admitted to departments
of rheumatology with a need for multidisciplinary re-
habilitation. We especially examined whether the extent
of using the multidisciplinary team of health care profes-
sionals (HCP) or of single health professions, before or




The study was designed as a multi-center, longitudinal
observational study, and relevant patients at the partici-
pating departments of rheumatology were consecutively
recruited and followed during the rehabilitation stay, at
discharge, and after 6 months. Four departments of
rheumatology in Eastern Norway participated over a 24-
month period.
Inclusion criteria
Patients were eligible if they had existing inflammatory
rheumatic disease at the time of admission, and
hospitalization was anticipated to last for at least one
week. Specifically, when consecutive patients were ad-
mitted as inpatients for any reason to departments of
rheumatology, then during the medical consultation at
admission a possible need for rehabilitation was
assessed. Such a need for rehabilitation during the stay
was defined as planned involvement of at least two HCP
(in addition to rheumatologist and nurse), thus fulfilling
a case requirement for delivering multidisciplinary care.
Thus, rehabilitation could be the major or a minor focus
of the inpatient stay. Patients were at age 18 years and
higher and signed informed consent to participate in the
study. The study was approved by the regional ethics
committee for Eastern Norway (REK 2004-13499).
Measurements
The diagnosis was recorded based on referral and exam-
ination at admission. Once included, patients completed
questionnaires on socio-demographic variables: age, gen-
der, level of education, marital status, work status, height
and weight. At admission patients indicated which HCP
they had consulted during the last year (general practi-
tioner, rheumatologist, orthopedic surgeon, nurse at gen-
eral practitioner’s office, nurse at the rheumatologist
office, physiotherapist, occupational therapist, manual
therapist, social worker, and psychologist).
Self-reported patient reported outcomes (PROs) in-
cluded pain, fatigue, and patient global assessment of
disease severity on 100 mm visual analog scales (VAS).
Physical disability was assessed by the Health Assess-
ment Questionnaire disability index (HAQ, 0-3) [17]
with upgrading of scores due to devices or help from an-
other person. Physical function and mental function
were also assessed using the Short-Form 36 (SF-36)
Health Survey with physical (PCS) and mental (MCS)
component summaries on 0-100 scales (100 = best func-
tioning) [18]. The Arthritis Self-Efficacy Scales [19] for
pain and symptoms with range 10-100 (100 = best) were
used to assess self-efficacy or the believe in the capability
to carry out a behaviour, and which reflects a concept of
perceived control. Rheumatoid arthritis disease activity
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index (RADAI) has questions on disease activity, joint
tenderness, pain, morning stiffness and perceived joint
pain in 16 joint areas [20]. The utility measure (SF-6D)
was derived from the responses to the SF-36 question-
naire based on an algorithm developed by Brazier [21]
and can be used for analyses in health economy (range
0.3-1, 1 = perfect health).
At discharge from the hospital, and at three and six
months follow-up, patients again completed question-
naires with identical PROs as during admission. At
discharge patients again ticked off from a list consulta-
tions during the stay with ten members of the multidis-
ciplinary team (rheumatologist, orthopaedic surgeon,
nurse, physiotherapist, occupational therapist, social
worker, psychologist, dietician, pharmacist, orthopaedic
engineer).
Statistical analysis
Descriptive statistics are presented as means with
standard deviation (SD) or 95 % confidence intervals
for continuous data, or as percentages for counts. Ef-
fect sizes for change of health outcomes at follow-up
time points were assessed as standardized response
means (SRM), the mean change divided by standard
deviation at baseline. The effect sizes were interpreted
as small (SRM 0.2-0.5), moderate (SRM 0.5-0.8), and
large (SRM >0.8) [22].
Consultation with HCP during rehabilitation was
grouped into tertiles: high HCP use (>6 professions),
medium HCP use (5 professions), and low HCP use (<4
professions). For the year preceding inpatient rehabilita-
tion the tertiles were >5, 3-4, and <2 professions,
respectively.
Comparisons between completers and non-
completers of the study, and between high and low
HCP use were performed with independent samples
t-tests for continuous and chi square tests for cat-
egorical variables. Analysis of variance (ANOVA) and
chi square tests compared baseline values for the dif-
ferent diagnoses. PRO values at discharge, and at 3-
and 6 months follow-up were compared with baseline
using paired samples t-tests.
Linear regressions mixed models with random inter-
cept by patient were applied including data from all
patients over the whole study period, defining individ-
ual health outcomes as dependent variables, and ana-
lysing time, age, gender, diagnosis, education, marital
status, use of HCP and baseline outcome value as in-
dependent variables. We then included the interaction
between use of multidisciplinary team*time in the
regression model, thus analysing the time dependent
effects of high versus low HCP use on specified
outcomes.
P-values <0.05 were considered significant. No correc-
tion for multiple testing was performed. SPSS version
21.0 (IBM) was used for the statistical analyses.
Results
The demographic and clinical baseline characteristics of
all 373 included patients and those 317 (85.0 %) com-
pleting the 6 months follow-up are displayed in Table 1.
Completers were older, more often female, married or
cohabiting, and had a shorter hospital stay than non-
completers. There were no statistically significant
differences in baseline PROs between completers and
non-completers.
RA was the most prevalent diagnosis in among in-
cluded patients, observed in 196 patients (52.5 %),
followed by ankylosing spondylitis in 72 (19.3 %) and
psoriatic arthritis in 66 (17.7 %) patients, while 39 pa-
tients (10.5 %) had other inflammatory rheumatic diag-
noses (systemic lupus erythematosus, systemic sclerosis,
mixed connective tissue disease, palindromic rheuma-
tism, vasculitis). Baseline characteristics in these four
groups were similar for most variables, but some statisti-
cally significant differences were seen: age and physical
disability (HAQ) were significantly higher for RA, dis-
ease duration and length of hospital stay shortest for
psoriatic arthritis, while the frequency of females was
lowest for AS, and the level of fatigue highest in the
group with other inflammatory diagnoses (data not
shown, ANOVA p < 0.05).
Changes in PRO
Table 2 display results for unadjusted PROs at admis-
sion, discharge, 3 and 6 months follow-up for study
completers. At discharge all the PROs were statistically
significantly improved, but the effects wore off, and at
6 months follow-up only pain, fatigue, SF-6D, SF-36
MCS and patient global assessment of disease activity
were statistically significantly improved as compared to
baseline assessment at admission to the department, but
corresponded to no more than at most small effect sizes
at 3- and 6 months follow-up.
The standardized improvements of PRO are shown in
Fig. 1a-e with means of SRM at departure, 3 month and
6 month follow-up. SRMs are shown for all patients and
according to the specific inflammatory rheumatic diag-
nosis. While up to moderate effect sizes were seen at de-
parture, at 3- and 6-months follow-up only, only small
effect sizes around 0.2 were observed. The effect sizes
were highest for pain, fatigue and SF6D-utility.
Changes outcomes were then adjusted for a number of
covariates and for baseline values and are shown in
Table 3, providing estimated marginal means with 95 %
CI. For easier interpretation, statistically significant find-
ings are given in bold types. Of all PRO only SF-36
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MCS, pain, and SF-6D utility were still significantly im-
proved at 6 months follow-up and fatigue was statisti-
cally significantly improved until 3 months follow-up.
Consultation with HCP
During the year preceding the admission for the rehabilita-
tion stay patients had median 3 (interquartile range 2-5)
HCP consultations, with a range 0 to 9 HCP. The corre-
sponding numbers for HCP consultation during inpatient
rehabilitation was median 5 (interquartile range 4-6)
consultations, ranging from 0 to 9. The frequency of
consultations with the individual HCP in the year prior to
the study and during the hospital stay is shown in Fig. 2a-b.
We did not find any consistent association between
consultations with any specific single HCP prior to or
during rehabilitation, and change in health outcomes at
discharge or follow-up (data not shown).
PRO levels were in general not statistically significantly
different between high and low use of HCP (highest vs.
lowest tertile) in the year before or during the rehabilita-
tion stay (Table 4), but for physical function (HAQ and
SF-36 PCS), fatigue and utility at admission levels were
Table 1 Demographic and baseline clinical characteristics for all patients
All (n = 373) Completers (n = 317) Non-completers (n = 56) P-valuea
Age (years) 52.6 (14.2) 53.3 (14.0) 49.0 (15.0) 0.034
Gender (% females) 74 77 59 0.004
Married/cohabiting (%) 64.6 68.7 48.2 0.045
Education (College/University, %) 27.2 25.6 37.2 0.14
Rheumatoid arthritis (%) 52 53 48 0.14
Disease duration (yrs) 13.4 (11.0) 13.1 (10.9) 14.7 (11.0) 0.32
Hospital days 14.1 (6.9) 13.4 (6.5) 17.9 (8.0) 0.001
Working (%) 35.3 34.3 41.5 0.31
HAQ (0-3) 1.23 (0.67) 1.21 (0.66) 1.33 (1.71) 0.20
SF-36 PCS (0-100) 30.3 (10.1) 30.1 (10.0) 30.2 (10.8) 0.95
SF-36 MCS (0-100) 44.9 (12.7) 45.4 (12.4) 42.0 (14.2) 0.07
Pain (0-100) 49.9 (24.7) 49.9 (24.7) 50.5 (25.2) 0.85
Fatigue (0-100) 59.9 (27.4) 59.2 (27.5) 63.8 (26.5) 0.26
Patient global (0-100) 48.8 (25.4) 48.3 (24.8) 52.2 (28.5) 0.29
RADAI (0-10) 4.5 (2.0) 4.4 (2.1) 4.5 (2.0) 0.86
Values are means with standard deviation or %
a Completers vs. non-completers
HAQ Health Assessment Questionnaire, SF-36 Short Form 36, PCS Physical component summary, MCS mental component summary, SES Self-Efficacy Scales, RADAI
Rheumatoid Arthritis Disease Activity Index
Table 2 Patient reported outcomes for completers at admission and follow-up (n = 317)
Admission/Baseline Departure 3 months 6 months
HAQ (0-3) 1.21 (0.66) 1.16 (0.67)** 1.20 (0.66) 1.22 (0.68)
SF-36 PCS (0-100) 30.3 (10.0) 31.4 (9.6)** 31.0 (9.9) 31.1 (9.6)
SF-36 MCS (0-100) 45.4 (12.4) 46.9 (11.5)* 47.3 (11.8)** 47.3 (11.8)**
Pain (0-100) 49.8 (24.7) 40.6 (23.6)** 44.0 (24.2)** 45.7 (24.6)**
Fatigue (0-100) 59.2 (27.5) 53.8 (28.3)** 53.3 (28.0)** 54.5 (27.5)**
Patient global (0-100) 48.3 (24.8) 39.6 (22.8)** 44.5 (24.7)* 45.4 (24.4)*
SES pain (10-100) 54.0 (16.9) 57.5 (16.8)** 54.4 (16.7) 54.5 (17.1)
SES symptoms (10-100) 61.0 (15.2) 64.9 (15.3)** 62.8 (15.6)* 61.2 (15.8)
RADAI (0-10) 4.5 (2.1) 3.9 (1.9)** 4.3 (2.1) 4.4 (2.1)
Utility (SF-6D, 0-1) 0.596 (0.11) 0.618 (0.11)** 0.622 (0.12)** 0.621 (0.12)**
Values are means (standard deviation)
*p < 0.05 **p < 0.01 (paired t-test) versus baseline
HAQ Health Assessment Questionnaire, SF-36 Short Form 36, PCS Physical component summary, MCS mental component summary, SES Self-Efficacy Scales, RADAI
Rheumatoid Arthritis Disease Activity Index
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Fig. 1 (See legend on next page.)
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statistically significantly worse for patients with high use
of HCP in the year before admission.
Table 5 presents differences in patient reported out-
comes between the high and the low HCP-use groups.
These differences are given for these groups comparing
their respective changes over defined follow-up periods,
adjusting for covariates. The difference was calculated by
subtracting the change score in the low HCP-use group
from that in high HCP-use” group (Table 5). Findings
showed that no major differences in change scores be-
tween high and low HCP users were seen through all
PROs and for all follow-up periods. However, the nu-
merical differences indicated less improvement in the
high HCP use group, i.e. no further reduction compared
to the low HCP-use group. On the contrary, in the high
HCP-use group some statistically significant differences
with less improvement were seen at 3-months follow-up
(RADAI, SF-36 physical component, and patient global).
For example, while all patients after three months had a
numerical improvement in patient global assessment of
disease activity (-2.5 mm) (Table 3), there was a deterior-
ation of +6.6 mm in the high HCP-use group as com-
pared to the low HCP-use (Table 5).
Discussion
In this study we examined the effects of consultations
with HCP on clinical outcomes in patients with inflam-
matory rheumatic diseases admitted to departments of
rheumatology. For all patient groups, independent of
diagnosis and extent of HCP use, improvements for
PRO were mainly temporary and had largely levelled off
already at 3 months of the 6 months follow-up after the
rehabilitation stay. More importantly, involving a high
number of HCP or any specific HCP was not associated
with better health, measured as any of the PROs, neither
immediately after the rehabilitation stay nor delayed dur-
ing the next 3-6 months. Changes in health outcomes
were generally small. Almost all numeric and all statisti-
cally significant findings pointed towards better baseline
function and larger improvements during the stay in the
group with less involvement of HCP.
These findings are counterintuitive, as all efforts by
HCP are directed to alleviating disease burden and en-
hance coping with the disease. Most likely unmeasured,
and maybe unmeasurable factors contribute to involving
HPC in patients with perceived problems. The patients
will then not necessarily demonstrate better PRO in
follow-up assessments. Thus, our findings contribute to
a hypothesis that high use of the multidisciplinary team
is a marker of disability and of specific rehabilitation
needs, indicating more complicated disease where one
may not expect major improvement of health status. We
find it important to clearly state this conundrum, so
health care workers who spend much time with highly
disabled patients with inflammatory rheumatic disease
will not go discouraged when their rehabilitation efforts
(See figure on previous page.)
Fig. 1 Change scores (standardized response means) for rehabilitation outcomes during hospital stay, and after 3 and 6 months in (a) all patients,
and patients with (b) rheumatoid arthritis, (c) psoriatic arthritis, (d) ankylosing spondylitis, (e) other diagnoses. HAQ Health Assessment
Questionnaire, SF36 PCS Short Form 36 physical component summary, SF36 MCS Short Form 36 mental component summary; SF-6D Short Form 6
dimensions, RADAI Rheumatoid Arthritis Disease Activity Index, Patglob Patient Global Assessment of disease activity, SES = Self-Efficacy Scales
Table 3 Changes from baseline scores for patient reported outcomes (PRO)
Change (n = 317)
Discharge - Baseline 3 months – Baseline 6 months - Baseline
HAQ -0.09 (-0.13 to -0.2) -0.04 (-0.14 to 0.03) 0.03 (-0.09 to 0.03)
SF-36 PCS 1.1 (0.1 to 2.1) 0.4 (-0.6 to 1.4) 0.6 (-0.5 to 1.6)
SF36 MCS 2.1 (0.6 to 3.5) 2.3 (0.9 to 3.8) 2.3 (0.8 to 3.8)
Pain -9.4 (-12.5 to -6.4) -5.0 (-8.1 to -1.9) -3.8 (-7.0 to -0.7)
Fatigue -5.1 (-8.3 to -1.8) -3.5 (-6.9 to -0.2) -3.0 (-6.3 to 0.4)
Patient global -8.9 (-12.1 to -5.7) -2.5 (-5.7 to 0.7) -2.0 (-5.3 to 1.2)
SES pain 3.28 (1.1 to 5.5) -0.1 (-2.4 to 2.1) -0.1 (-2.4 to 2.2)
SES symptoms 4.1 (2.1 to 6.0) 1.8 (-0.1 to 3.8) -0.1 (-2.1 to 1.9)
RADAI -0.66 (-0.90 to -0.41) -0.11 (-0.37 to 0.14) -0.07 (-0.33 to 0.18)
SF6D 0.028 (0.014 to 0.042) 0.027 (0.012 to 0.041) 0.028 (0.014 to 0.042)
Values are estimated marginal means with 95 % confidence intervals, adjusted for age, gender, diagnosis, education, marital status, use of health professionals
and baseline
Statistically significant change scores shown in bold types
HAQ Health Assessment Questionnaire, SF-36 Short Form 36, PCS Physical component summary, MCS mental component summary, SES Self-Efficacy Scales, RADAI
Rheumatoid Arthritis Disease Activity Index
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do not show as improvements demonstrated by means
of standardized PROs.
Future research mandates to quantify study ele-
ments of efforts made by the individual HCP. Only a
randomized controlled trial which compares high and
low levels of multidisciplinary rehabilitation, could
study whether the broad multidisciplinary team pro-
vides better health outcomes. This should also include
proper goal setting process and coordinated multidis-
ciplinary team-care in many of these patients, which
is now recommended [23].
Rehabilitation in inflammatory joint diseases has also in
other studies shown at least short lived improvements. A
three-week multidisciplinary day-care program has early
shown to be beneficial in patients with RA [24], and a
number of studies has shown at least temporary improve-
ment after multidisciplinary team care in mixed popula-
tions [25, 26], especially in patients with rheumatoid
arthritis [13, 14, 16, 24, 27–29] and ankylosing spondylitis
[10]. As a typical finding scores in patients with inflamma-
tory rheumatic disease after 6 months again have reached
baseline [30], suggesting supportive follow-up interven-
tions to possibly maintain outcome improvement [31].
Disappointing in the results of our study was also the ob-
served lack of lasting improvement of self-efficacy, which
could be expected to improve after involvement of the
multidisciplinary team. Our findings indicate that self-
management issues were not effectively addressed even in
Fig. 2 Consultations of patients (n = 317) with health care professions (a) in the year preceding (b) during the hospital stay. GP General
Practitioner, Occup. Therapist Occupational Therapist, Orthop. Surgeon Orthopedic Surgeon, Orthop. Engineer Orthopedic Engineer
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patients with high use of HCP in departments of
rheumatology.
Multidisciplinary team care has developed during the
last years with increasing focus on evidence-based evalu-
ation [32]. Due to the questionable responsiveness of
multidisciplinary team care [15], evaluation should be
function specific and overall physical disability [33]. We
therefore applied a wide range of outcome measures, in-
cluding physical function, pain, fatigue, health related
quality of life, but also self-efficacy and a utility measure
which could be applied for health economy. An
improvement in SF-36 derived utility of about 0.025
would – if maintained for one year - correspond to a
gain of 2.5 quality adjusted life years in 100 patients.
While our study did not examine the specific content
and intensity of rehabilitation, it investigated the involve-
ment of HCP, constituting the multidisciplinary team.
Strengths of this study are the relative large sample size
from four departments of rheumatology, inclusion of a
typical spectre of inflammatory rheumatic diseases, and
broad outcome assessments which also included disease
activity, self-efficacy and utility.
A number of limitations apply to our study. First, in-
cluded patients reported on use of HCP, but not further
on the contents of these consultations or rehabilitation in-
terventions. Further, rehabilitation in our study was most
likely given individualised to patients’ needs parallel to
other treatment modalities for the rheumatic disease at
regular hospital departments, which is again part of multi-
disciplinary treatment in itself, i.e. we did not evaluate
pharmaceutical modalities. Also, more tailored rehabilita-
tion interventions could have led to greater outcome ef-
fects. We gave patients in the questionnaires the
opportunity to state events which during the rehabilitation
stay could have affected outcomes, e.g. initiation of bio-
logical medication, surgical procedures, or infections.
Only a minority of patients made such statements, and we
did not systematically register all other medication, for ex-
ample analgetics, preventing us from specifically account-
ing for these factors in our analyses. Another limitation is
the observational design of the study which prevents
causal conclusions. Finally, our results are restricted to pa-
tients with inflammatory arthropathies, where some need
for rehabilitation was seen during regular admissions at
departments of rheumatology. This clinical setting does
Table 4 Baseline PROs for low and high usea of HCP the year before and during hospital stay
Variable Last year before rehabilitation (n = 317) During rehabilitation stay (n = 317)
Low use (<2) (n = 94) High use (>5) (n = 93) p- value Low use (<4) (n = 85) High use (>6) (n = 84) P-value
HAQ 1.08 (0.65) 1.42 (0.66) <0.001 1.20 (0.68) 1.35 (0.68) 0.60
SF36 PCS 32.4 (9.7) 27.6 (10.1) 0.001 30.2 (9.8) 27.7 (10.4) 0.11
SF36 MCS 44.7 (12.1) 45.2 (13.0) 0.79 44.7 (11.7) 43 (13.4) 0.40
Pain 52.3 (25.4) 53.7 (25.4) 0.71 50.1 (26.8) 51.9 (24.0) 0.66
Fatigue 56.2 (28.3) 65.2 (25.2) 0.023 58.9 (26.7) 64.8 (25.6) 0.15
Patient global 49.2 (27.2) 52.6 (23.0) 0.38 50.0 (26.0) 50.5 (23.7) 0.90
SES pain 55.6 (16.2) 54.2 (16.8) 0.57 52.9 (18.8) 53.3 (14.3) 0.90
SES symptoms 60.2 (14.7) 62.6 (13.9) 0.28 59.9 (14.4) 61.2 (14.6) 0.57
RADAI 4.40 (2.08) 4.80 (2.07) 0.20 4.72 (2.26) 4.60 (1.93) 0.72
SF6D 0.61 (0.12) 0.57 (0.10) 0.038 0.60 (0.11) 0.55 (0.10) 0.002
a Use of health care professionals is grouped in lowest and highest tertile. The intermediate tertile for last year before rehabilitation included 126 patients (missing
n = 4), and the tertile for during the rehabilitation stay included 134 patients (missing n = 14)
Values are means with standard variation and p-value from independent samples t-test
PRO Patient reported outcomes, HCP Health Care professionals, HAQ Health Assessment Questionnaire, SF-36 Short Form 36, PCS Physical component summary,
MCS mental component summary, SES Self-Efficacy Scales, RADAI Rheumatoid Arthritis Disease Activity Index
Table 5 Differences (Δ) between high and low users of the
multidisciplinary team observed for change in patient reported
outcomes during follow-up periods
Outcome High versus low use of health professionals
Discharge 3 months 6 months
ΔHAQ 0.09, p = 0.10 0.08, p = 0.13 0.03, p = 0.57
ΔSF-36 PCS 0.3, p = 0.77 -2.4, p = 0.023 -0.2, p = 0.85
ΔSF36 MCS -0.71, p = 0.62 0.60, p = 0.68 0.59, p = 0.69
ΔFatigue 1.3, p = 0.69 2.3, p = 0.49 0.2, p = 0.95
ΔPain 2.2, p = 0.48 5.9, p = 0.06 3.0, p = 0.34
ΔPatient global 0.8, p = 0.79 6.6, p = 0.04 0.7, p = 0.85
ΔSES pain 2.5, p = 0.26 0.4, p = 0.87 4.2, p = 0.07
ΔSES symptoms -0.2, p = 0.91 -1.5, p = 0.44 0.6, p = 0.74
ΔRADAI 0.33, p = 0.17 0.62, p = 0.012 0.17, p = 0.31
ΔSF6D -0.011, p = 0.44 -0.015, p = 0.29 -0.005, p = 0.74
Values are estimated marginal means with p-values, adjusted for age, gender,
diagnosis, education, marital status, use of health professionals and
baseline values
Statistically significant differences in change scores are shown in bold types
HAQ Health Assessment Questionnaire, SF-36 Short Form 36, PCS Physical
component summary, MCS mental component summary, SES Self-Efficacy
Scales, RADAI Rheumatoid Arthritis Disease Activity Index
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represent predefined major rehabilitation needs, and our
findings can thus not be generalized to rehabilitation
effects.
More focus on goals and other aspects of rehabilita-
tion could have led to better health outcomes than seen
in our study. In fact, we know that the different depart-
ments of rheumatology do not have a unified practice of
rehabilitation, and we do not know which specific re-
habilitation modalities were applied in our patients.
Conclusions
This study addressed rehabilitation outcomes until 6
months in inpatients with inflammatory rheumatic dis-
eases, finding small and mainly short-term improve-
ments in a wide range of PRO. High use as compared to
low use of HCP in a multidisciplinary team did not en-
hance or preserve rehabilitation outcomes. High use of
HCP was, however, associated to poorer PRO at base-
line, and these findings illustrate that in clinical practice
resources are used according to clinical need. Research
using randomized controlled trials is warranted to study
how effective multidisciplinary teams are in the rehabili-
tation of inflammatory rheumatic diseases.
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